tiprankstipranks
Palvella Therapeutics (PVLA)
NASDAQ:PVLA
US Market

Palvella Therapeutics (PVLA) Income Statement

Compare
601 Followers

Palvella Therapeutics Income Statement

Last quarter (Q3 2024), Palvella Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Palvella Therapeutics's net income was $-2.89M. See Palvella Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 42.81M$ 25.90M$ 31.42M$ 29.32M$ 46.28M
Gross Profit
$ 1.01M$ 23.12M$ 29.05M$ -17.21M$ -8.72M
Operating Expenses
$ 72.57M$ 61.20M$ 79.56M$ 63.24M$ 73.44M
Depreciation and Amortization
$ 1.78M$ 2.78M$ 2.37M$ 2.13M$ 1.04M
EBITDA
$ -22.76M$ -30.50M$ -43.37M$ -31.61M$ -26.12M
Operating Income
$ -29.76M$ -43.47M$ -51.83M$ -33.92M$ -27.16M
Other Income/Expenses
$ 5.21M$ 10.20M$ 6.09M$ -3.15M$ 1.69M
Pretax Income
$ -24.54M$ -33.28M$ -45.74M$ -37.07M$ -25.47M
Net Income
$ -24.54M$ -31.25M$ -43.37M$ -37.23M$ -23.75M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -21.80$ -33.71$ -53.75$ -54.67$ -37.54
Diluted EPS
$ -21.80$ -33.71$ -53.75$ -54.67$ -37.54
Weighted Average Shares Outstanding
1.13M 927.15K 806.84K 681.01K 632.81K
Weighted Average Shares Outstanding (Diluted)
1.13M 927.15K 806.84K 681.01K 632.81K
Currency in USD

Palvella Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis